zyou(at)cimrbj.ac.cn
The You lab at CIMR investigates the molecular mechanisms of DNA/RNA surveillance and the innate immune response system, with the goal of translating the discoveries into new therapies for cancer and autoimmune diseases.
1. Interplay between genome stability, RNA surveillance, and innate immunity
2. Regulatory roles of TRPV2 and other ion channels in cGAS/STING-mediated innate immune responses
3. Exploiting the TRPV2–STING axis for the treatment of cancer and autoimmune diseases
4. Targeting NMD pathway for the treatment of cancers with spliceosome mutations
1. Identified a novel cytosolic DNA-elicited, Ca2+-mediated signaling pathway that safeguards DNA replication forks to maintain genome stability (Mol Cell, 2019; Mol Cell, 2023; Nat Commun, 2024).
2. Uncovered a novel interplay on the endoplasmic reticulum between the ion channel TRPV2 and the innate immune factor STING, revealing a new mechanism that co-regulates Ca2+ dynamics and immune activation (Mol Cell, 2023; Cell Rep, in press).
3. Pioneered the development of NMD reporter systems, leading to the identification of novel NMD inhibitors and genetic regulators, and demonstrated that NMD is modulated by intracellular Ca2+ and persistent DNA damage (Nat Med, 2014; J Biol Chem, 2017).
4. Identified NMD as a promising therapeutic target for cancers with spliceosome mutations (Cancer Res, 2021).